First-time prescribing of ADMs decreased in September 2025, relative to June 2025 (-16.8%)
While treatments can lag diagnosis and disease pre-dates treatment, these increases in treatment rates represent a positive development for many patients
The previous Hims subscription required a 6-month commitment, so the new monthly cadence gives you a lower-cost way to try the membership
Semaglutide is a GLP-1 (glucagon-like peptide-1) mono satiety hormone activatora medication that mimics a naturally occurring hormone in the body that helps regulate appetite and blood sugar levels
Early news stories about GLP-1s, particularly as they are used for weight loss, forecast sky high sales within just a few years
In a recent study, researchers found that most users regain two-thirds of the weight they lost within 6 to 12 months after stopping the drug